Our Team

Meet Jim Menoutis

Co-Founder, Scientific, Technical & Management Leadership

Jim Menoutis is an accomplished analytical chemist and seasoned manager with more than four decades of experience leading laboratory operations and technical programs in highly regulated environments. He earned his B.S. in Chemistry (Biochemistry concentration) and Mathematics, with an advanced minor in Physics (Engineering & Computational Physics), and went on to complete his Ph.D. in Analytical Chemistry. He also holds a certificate in Toxicology along with several other professional certifications that expand his expertise across analytical sciences and quality systems.

During his graduate studies, Jim served as a graduate intern with a research organization collaborating on asbestos studies. Shortly after completing his graduate studies, he became a Group Leader there, overseeing validation of the then-proposed EPA 600-series methods (601–625) under contracts from SRI, Battelle Laboratories, and Southwest Research Institute.

Subsequently, he worked in the toxicology group of a leading international testing and inspection organization, where he gained early experience in chemical safety and applied regulatory science. He later served as an Analytical Laboratory Group Supervisor for one of the largest clinical laboratories in the United States, before advancing into senior scientific and quality leadership roles at major national and global pharmaceutical companies. Over the course of his career, he has established himself as a Subject Matter Expert (SME) in method development, validation, elemental impurity testing, genotoxic impurity assessment, and regulatory compliance, with deep expertise in the associated analytical techniques. His published work includes significant contributions on elemental and genotoxic impurities, as well as the detection of trace and ultra-trace contaminants and impurities.

As a co-founder of Quantum Analytics Group, Jim directs the scientific and quality strategy, integrating ISO/IEC 17025:2017 and FDA cGMP (21 CFR 210/211, 820) standards into every aspect of the laboratory’s operations. His career is distinguished by a commitment to accuracy, robust quality systems, and mentoring the next generation of scientists. Beyond the laboratory, Jim is an Emeritus Board Member of the New Jersey Pharmaceutical Quality Control Association, a Fellow of the American Institute of Chemists, a Member of the American Chemical Society, the American Association of Pharmaceutical Scientists, the Society of Cosmetic Chemists, and a Board Member of the New Jersey Institute of Chemists.  He previously served on the Board of his undergraduate alma mater. In addition to his scientific and professional leadership, Jim is a Lieutenant Colonel in the United States Air Force Auxiliary, where he serves as a Group Commander, a pilot,  and is a graduate of the Northeast Region Staff College.

Angela Parisi Menoutis

Senior Scientist, QA & Laboratory Operations Leader

Angela Parisi Menoutis is a senior scientist and laboratory operations leader with more than four decades of experience in both research & development and regulated quality testing. She holds dual Bachelor of Science degrees in Chemistry and Biology and has completed significant graduate coursework toward a Master of Science in Chemistry. Early in her career, she trained under renowned chemists Dr. Grob and Dr. Snyder, and attended the Finnigan Institute, where she received advanced instruction in mass spectrometry and studied with mass spectrometry pioneer Dr. Fred McLafferty.

Throughout her career, Angela has held critical management roles directing laboratory operations, overseeing the Quality Assurance (QA) function, method development, and guiding R&D programs for major global organizations in the pharmaceutical, biotechnology, and consumer products industries. She was also involved in supporting drug discovery and the development of oncology therapeutics, and has extensive experience as a Subject Matter Expert (SME)  designing and conducting dissolution studies to support drug formulation, characterization, and development efforts.

Her expertise spans cGMP laboratory operations, ISO/IEC 17025 quality systems, analytical method development, and advanced instrumental analysis—areas where she is also recognized as an SME. She has authored and co-authored publications on elemental impurities, genotoxic impurities, and trace-level contaminant testing, contributing to the advancement of industry best practices.

In addition to her scientific career, Angela is also a published author of two historical fiction books, reflecting her passion for history, research, and storytelling. At Quantum Analytics Group, Angela leverages her deep technical background and leadership experience to integrate QA oversight with laboratory operations, ensuring a robust dual-compliance quality system and mentoring the next generation of scientists so that every result meets the highest scientific and regulatory standards.

Dimitri Kitsos

Co-Founder, Manager of Regulatory Services

Dimitri Kitsos is a co-founder of Quantum Analytics Group and serves as Manager of Regulatory Services. He holds a B.S. in Chemistry and a Ph.D. in Organic Chemistry, and brings more than three decades of experience guiding pharmaceutical, drug development, and specialty chemical programs in both the U.S. and Europe.

With over three decades of experience in R&D, Quality Assurance, and GMP-regulated analytical laboratories, Dimitri has held leadership roles including Principal Scientist, Group Leader, and Group Manager. He specializes in leveraging advanced LC/MS technologies to address complex challenges—from exploratory compound development to impurity profiling and regulatory submissions.

At Quantum Analytics Group, Dimitri’s blend of scientific depth and regulatory insight helps clients navigate the most demanding quality expectations. He works closely with partners to ensure methods are not only scientifically sound but also fully aligned with FDA and international regulatory standards—delivering results that are accurate, reliable, and audit-ready.

Mary Oppel

Manager of Business Development

Mary Oppel serves as Manager of Business Development at Quantum Analytics Group, where she combines her background in communications with a strong, self-taught expertise in bioengineering. In this dual capacity, she drives client engagement, strategic partnerships, and new business opportunities, while also contributing unique technical insight drawn from her hands-on work in sensor design and advanced biosensor technologies.

Mary earned her B.S. in Communication and Journalism, equipping her with the skills to build clear, effective relationships with clients and stakeholders. Beyond her formal education, she pursued independent study and practical development in bioengineering, focusing on sensor innovation and device integration. This unconventional path led her to become a named inventor on patents covering sophisticated biosensor systems, demonstrating her ability to merge creativity, scientific curiosity, and technical skill.

Mary’s unique blend of communication expertise and self-driven technical innovation makes her a vital bridge between Quantum Analytics Group’s scientific teams and its clients. She is committed to fostering growth through trust, clarity, and collaboration—while ensuring that the company’s advanced analytical capabilities reach industries where accuracy and innovation matter most.

Jonathan Menoutis

Manager, Client Services & Project Management

Jonathan Menoutis brings 14 years of progressive experience in the contract analytical laboratory industry, with expertise spanning pharmaceuticals, medical devices, and personal care products. He began his career as a laboratory technician, gaining hands-on analytical experience while completing his Associate’s Degree in Science with a concentration in Chemistry.

Building on his technical foundation, Jonathan advanced into roles supporting drug discovery, development, and quality, where he served as a project manager overseeing diverse client programs. During this time, he earned his B.S. in Business Administration, complementing his scientific background with strong business and management skills. He went on to broaden his experience with a major contract testing laboratory while earning a Graduate Certificate in Project Management, further strengthening his leadership in coordinating complex, multi-disciplinary projects. Jonathan is currently completing his MBA and preparing to sit for the Project Management Professional (PMP®) exam through PMI.

At Quantum Analytics Group, Jonathan serves as Manager of Client Services and Project Management, where he oversees client relations, project coordination, and operational execution. His combination of technical knowledge, business acumen, and project management expertise ensures that client programs are delivered with precision, efficiency, and regulatory compliance.

Douglas Devaney

Manager of Information Technology

Douglas Devaney serves as Manager of Information Technology at Quantum Analytics Group, bringing more than 11 years of IT leadership experience in regulated laboratory and enterprise environments. A U.S. Air Force veteran with an honorable discharge and a graduate of a leading IT technical institute, he combines technical expertise with the discipline and mission focus instilled by his military service.

Prior to joining Quantum Analytics Group, Doug built his career across both the laboratory and corporate IT sectors. He first worked for a major regional analytical testing laboratory supporting the pharmaceutical, medical device, and personal care products industries, where he gained direct experience managing IT operations in a cGMP environment. He later advanced to a leadership role with one of the largest global providers of IT infrastructure, end-user computing, cybersecurity, and IT optimization solutions, further strengthening his expertise in enterprise-level systems and secure IT operations.

At Quantum Analytics Group, Doug applies this combined experience to lead the design, validation, and governance of laboratory IT systems. He has overseen the implementation of secure and compliant platforms in alignment with FDA regulations including 21 CFR Parts 210, 211, 820, and Part 11, and has championed robust data integrity programs built on ALCOA+ principles. He is highly experienced with laboratory informatics, including Agilent ChemStation with ChemStore, Agilent OpenLab, Waters Empower, and LIMS platforms, ensuring that data generated within the laboratory remains reliable, traceable, and defensible. By integrating IT infrastructure management, cybersecurity, disaster recovery planning, and quality system requirements such as change control and CAPA, Doug ensures that Quantum Analytics Group maintains a strong, compliant, and resilient digital backbone. His leadership enables the laboratory to operate with both technological strength and regulatory integrity, supporting its mission to deliver accurate, defensible, and timely results for the pharmaceutical, medical device, personal care, and specialty chemical industries.